TFC-003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TFC-003, covering 2023-12-20 to 2023-12-20. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 2]